Harrisburg, PA: Pennsylvania Health Secretary Rachel Levine has signed off on a series of recommendations expanding patients' access to medical cannabis.
The changes, previously recommended by the state's medical marijuana advisory board, expand the pool of patients eligible to receive medical cannabis therapy to include those suffering from opioid dependency, neurodegenerative diseases, and/or dyskinetic or other spastic movement disorders. Patients undergoing cancer remission therapy are also now eligible to access medical cannabis. Chronic pain patients will also have greater access to cannabis under the rule changes.
The new rules also for the first-time permit dispensaries to provide herbal cannabis preparations to qualified patients. As initially enacted, the program only permitted patients to access cannabis-infused pills, oils, topical ointments, or tinctures.
Under the new regulations, patients are permitted to vaporize, but not smoke, herbal cannabis.
"Pennsylvania's medical cannabis program may have gotten off to a bit of a rocky start, but patients can feel confident that the Advisory Board takes its role seriously and is committed to improving the program," said Pittsburgh NORML Director Patrick Nightingale.
For more information, contact Justin Strekal, NORML Political Director, at (202) 483-5500.